{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T23:40:03Z","timestamp":1738366803018,"version":"3.35.0"},"reference-count":22,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2008,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>For an adolescent with bacterial meningitis and subsequent cerebral aspergillosis, intravenous voriconazole dose requirements substantially decreased during coadministration with intravenous chloramphenicol and considerably rose after discontinuation of the antibiotic. In agreement with in vitro evidence, these data suggest that chloramphenicol is a rather significant inhibitor of hepatic CYP3A4 and\/or CYP2C19.<\/jats:p>","DOI":"10.1128\/aac.00805-08","type":"journal-article","created":{"date-parts":[[2008,9,16]],"date-time":"2008-09-16T01:36:10Z","timestamp":1221528970000},"page":"4172-4174","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":13,"title":["Inhibition of Voriconazole Metabolism by Chloramphenicol in an Adolescent with Central Nervous System Aspergillosis"],"prefix":"10.1128","volume":"52","author":[{"given":"Verena","family":"Hafner","sequence":"first","affiliation":[{"name":"Department of Internal Medicine VI, Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Im Neuenheimer Feld 410, D-69120 Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Albermann","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Neonatology, Im Neuenheimer Feld 153, D-69120 Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter E.","family":"Haefeli","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine VI, Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Im Neuenheimer Feld 410, D-69120 Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedrich","family":"Ebinger","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Pediatric Neurology, Im Neuenheimer Feld 153, D-69120 Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0090-9556(25)06850-3","volume":"15","year":"1987","unstructured":"Ciaccio, P. J., D. B. Duignan, and J. R. Halpert. 1987. Selective inactivation by chloramphenicol of the major phenobarbital-inducible isozymes of dog liver cytochrome P-450. Drug Metab. Dispos.15:852-856.","journal-title":"Drug Metab. Dispos."},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/MCC.0b013e32827851d7","volume":"13","year":"2007","unstructured":"Falagas, M. E., and P. Kopterides. 2007. Old antibiotics for infections in critically ill patients. Curr. Opin. Crit. Care13:592-597.","journal-title":"Curr. Opin. Crit. Care"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0026-895X(25)14162-X","volume":"28","year":"1985","unstructured":"Halpert, J., C. Balfour, N. E. Miller, E. T. Morgan, D. Dunbar, and L. S. Kaminsky. 1985. Isozyme selectivity of the inhibition of rat liver cytochromes P-450 by chloramphenicol in vivo. Mol. Pharmacol.28:290-296.","journal-title":"Mol. Pharmacol."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020191"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.31.5.540"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/cpt1978245571","volume":"24","year":"1978","unstructured":"Koup, J. R., M. Gibaldi, P. McNamara, D. M. Hilligoss, W. A. Colburn, and E. Bruck. 1978. Interaction of chloramphenicol with phenytoin and phenobarbital. Clin. Pharmacol. Ther.24:571-575.","journal-title":"Clin. Pharmacol. Ther."},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1034\/j.1399-3062.2002.t01-3-02001.x","volume":"4","year":"2002","unstructured":"Mathis, A. S., N. Shah, G. T. Knipp, and G. S. Friedman. 2002. Interaction of chloramphenicol and the calcineurin inhibitors in renal transplant recipients. Transpl. Infect. Dis.4:169-174.","journal-title":"Transpl. Infect. Dis."},{"key":"e_1_3_2_9_2","first-page":"635","volume":"54","year":"2002","unstructured":"Ogutu, B. R., C. R. Newton, S. N. Muchohi, G. O. Otieno, and G. O. Kokwaro. 2002. Phenytoin pharmacokinetics and clinical effects in African children following fosphenytoin and chloramphenicol coadministration. Br. J. Clin. Pharmacol.54:635-642.","journal-title":"Br. J. Clin. Pharmacol."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.11.3464-3469.2003"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2007.118844"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1365-2125.2003.01999.x","volume":"56","year":"2003","unstructured":"Purkins, L., N. Wood, D. Kleinermans, and D. Nichols. 2003. Histamine H2-receptor antagonists have no clinically significant effect on the steady-state pharmacokinetics of voriconazole. Br. J. Clin. Pharmacol.56:51-55.","journal-title":"Br. J. Clin. Pharmacol."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2005.01.024"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s002280000166","volume":"56","year":"2000","unstructured":"Rivory, L. P., H. Qin, S. J. Clarke, J. Eris, G. Duggin, E. Ray, R. J. Trent, and J. F. Bishop. 2000. Frequency of cytochrome P450 3A4 variant genotype in transplant population and lack of association with cyclosporin clearance. Eur. J. Clin. Pharmacol.56:395-398.","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199805270-00020"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000202421.94822.f7"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.4.1570-1572.2006"},{"key":"e_1_3_2_18_2","first-page":"203","volume":"49","year":"2005","unstructured":"Stiefel, M., T. Reiss, M. S. Staege, J. Rengelshausen, J. Burhenne, A. Wawer, and J. L. Foell. 2005. Successful treatment with voriconazole of aspergillus brain abscess in a boy with medulloblastoma. Pediatr. Blood Cancer49:203-207.","journal-title":"Pediatr. Blood Cancer"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(00)00934-9"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200203000-00015"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.6.2166-2172.2004"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.02000.x"},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0022-3565(25)21612-3","volume":"231","year":"1984","unstructured":"Yacobi, A., C. M. Lai, and G. Levy. 1984. Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and chloramphenicol in rats. J. Pharmacol. Exp. Ther.231:80-84.","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00805-08","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00805-08","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T23:09:39Z","timestamp":1738364979000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00805-08"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["10.1128\/AAC.00805-08"],"URL":"https:\/\/doi.org\/10.1128\/aac.00805-08","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"type":"print","value":"0066-4804"},{"type":"electronic","value":"1098-6596"}],"subject":[],"published":{"date-parts":[[2008,11]]},"assertion":[{"value":"2008-06-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2008-09-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2008-11-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}